A. Kenison Roy

Dr. A. Kenison Roy, III serves as an Associate Professor of Psychiatry and Addiction Medicine at Tulane School of Medicine, where he also leads the Division of Addiction Medicine and directs the Addiction Medicine Fellowship program. A Distinguished Life Fellow of the American Psychiatric Association and a Distinguished Fellow of the American Society of Addiction Medicine (ASAM), Dr. Roy is a recognized leader in addiction medicine. He is triple board-certified in Psychiatry, Addiction Medicine, and Preventive Medicine in Addiction Medicine, reflecting his dedication to advancing evidence-based care in the field. Dr. Roy's contributions to professional organizations are extensive, including past leadership as President of the Louisiana Psychiatric Medical Association and Board membership in the American College of Academic Addiction Medicine (ACAAM). His affiliations span numerous respected societies, such as the American Academy of Addiction Psychiatry and the American College of Psychiatrists. Licensed to practice medicine in Louisiana and Mississippi, Dr. Roy is deeply committed to patient care, education, and shaping the next generation of addiction medicine specialists. Beyond his academic and clinical roles, Dr. Roy has made significant scholarly contributions, including co-authoring research on innovative approaches to managing reward dysregulation in primary care through genetic risk testing and dopamine homeostasis. His work has been published in peer-reviewed journals like the International Journal of Environmental Research and Public Health. He is a frequent speaker at national and international conferences, delivering presentations on topics ranging from the neurobiology of spirituality to advanced clinical practices in addiction medicine. Dr. Roy is also actively involved in education at Tulane University, conducting Grand Rounds and delivering lectures to second-year medical students, psychiatry residents, and addiction medicine fellows. He has presented his expertise at national forums, including the National Addictive Disorders Conference and other professional gatherings. His commitment to advancing the field of addiction medicine through research, education, and advocacy underscores his standing as a leader in this critical area of healthcare.